1. Home
  2. Labeler Index
  3. Florida Pharmaceutical Products, Llc
  4. 71921-177
  5. Product Images: Abiraterone Acetate

Product Images Abiraterone Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Abiraterone Acetate NDC 71921-177 by Florida Pharmaceutical Products, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Bottle label - Abiraterone Acetate Tablets USP 500 mg Label

Bottle label - Abiraterone Acetate Tablets USP 500 mg Label

Abiraterone acetate is a medication provided in the form of film-coated tablets that contains 500 mg of the active ingredient in each tablet. The recommended dosage for abiraterone acetate can be found in the prescribing information. Store the tablets at room temperature between 20°C to 25°C, and maintain temperatures between 15°C and 30°C. Keep the product out of the reach of children and swallow the tablets whole, without crushing or chewing them. This medication is manufactured in India and distributed in the United States by Florida Pharmaceutical Products LLC. It is only available with a prescription.*

Figure 1 - Figure 1

Figure 1 - Figure 1

The text provides a survival rate graph comparing the effects of Abiraterone Acetate Tablets and Placebo over time. Abiraterone Acetate Tablets demonstrate a higher survival rate than Placebo. However, the graph's title, additional details on its parameters, and its context are not available.*

Figure 2 - Figure 2

Figure 2 - Figure 2

This appears to be a graph depicting the results of a study involving Abiraterone Acetate tablets and a placebo over the course of several months post-randomization. The y-axis contains various numeric values while the x-axis denotes the time in months. The graph may be indicating the effectiveness of the medication.*

Figure 3 - Figure 3

Figure 3 - Figure 3

This document seems to be a table with some information on Abiraterone Acetate tablets and the placebo. However, it is not clear what the numbers mean and how to interpret them without further context.*

Figure 4 - Figure 4

Figure 4 - Figure 4

This is a table showing the number of patients for whom Abiraterone Acetate was administered in a clinical trial over a period of 72 months with column headers "Subjects at risk" and "Months from Randomization". The table contains information for patients who received a placebo as well. However, no further information about the trial is given, and hence it is difficult to analyze the results.*

Structure - Structure

Structure - Structure

f8c59784 d6d5 285c e053 6294a90a4f4b

f8c59784 d6d5 285c e053 6294a90a4f4b

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.